WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013147439) SYSTEMIC IMMUNITY OR GUT IMMUNITY ADJUVANT COMPRISING CHEONGGUKJANG EXTRACTS AS ACTIVE INGREDIENT
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/147439 International Application No.: PCT/KR2013/001945
Publication Date: 03.10.2013 International Filing Date: 11.03.2013
IPC:
A61K 36/48 (2006.01) ,A61P 39/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
185
Magnoliopsida (dicotyledons)
48
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
39
General protective or antinoxious agents
Applicants: KOREA FOOD RESEARCH INSTITUTE[KR/KR]; 62, Anyangpangyo-ro 1201beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-746, KR
Inventors: SHON, Dong-Hwa; KR
LIM, Seong-Il; KR
CHOI, Dae Woon; KR
CHUNG, In Sik; KR
KIM, Won-Yong; KR
SEE, Hye-Jeong; KR
HWANG, In-Kyu; KR
Agent: YANG, Boo-Hyun; Suite 301, Chungdong Building 1659-2 Inhundong, Gwanak-gu, Seoul 151-832, KR
Priority Data:
10-2012-003174928.03.2012KR
10-2013-001889521.02.2013KR
Title (EN) SYSTEMIC IMMUNITY OR GUT IMMUNITY ADJUVANT COMPRISING CHEONGGUKJANG EXTRACTS AS ACTIVE INGREDIENT
(FR) IMMUNITÉ SYSTÉMIQUE OU ADJUVANT D'IMMUNITÉ INTESTINALE COMPRENANT DES EXTRAITS DE CHEONGGUKJANG COMME PRINCIPE ACTIF
(KO) 청국장 추출물을 유효성분으로 포함하는 전신면역 또는 장관면역 보강제
Abstract:
(EN) The present invention relates to a systemic immunity or gut immunity adjuvant comprising ethanol-soluble cheonggukjang extracts as active ingredients. The immunity adjuvant comprising ethanol-soluble cheonggukjang extracts according to the present invention uses food materials with assured safety to prevent the risk of toxicity and side effects and enable low production cost and provide convenience in use. Furthermore, the immunity adjuvant of the present invention can induce Th1 and Th2 response not only against oral infectious pathogenic microorganisms but also non-oral infectious pathogenic microorganisms, virus, cancer antigens, general antigens or the like when taken orally together with immunogen, and can produce an effective specific antibody (IgG in blood and IgA in the small intestine).
(FR) La présente invention concerne un adjuvant d'immunité intestinale ou une immunité systémique comprenant des extraits de cheonggukjang solubles dans l'éthanol comme principes actifs. L'adjuvant de l'immunité comprenant des extraits de cheonggukjang solubles dans l'éthanol, utilise, selon la présente invention, des matières alimentaires avec une sécurité garantie pour empêcher le risque de toxicité et des effets secondaires et permettre un faible coût de production ainsi qu'une commodité lors de l'utilisation. En outre, l'adjuvant d'immunité de la présente invention peut induire une réponse Th1 et Th2 non seulement contre des micro-organismes pathogènes infectieux par voie orale, mais également autrement que par voie orale, des micro-organismes pathogènes infectieux, des virus, des antigènes de cancer, des antigènes généraux, ou analogues lorsqu'ils sont pris par voie orale conjointement avec un immunogène et peuvent produire un anticorps spécifique efficace dans le sang (IgG dans le sang et IgA dans l'intestin grêle).
(KO) 본 발명은 청국장 에탄올 용해(ethanol-soluble) 추출물을 유효성분으로 포함하는 전신면역 및 장관면역 보강제에 관한 것으로, 본 발명의 청국장 에탄올 용해(ethanol-soluble) 추출물을 포함하는 면역보강제는 안전성이 확보된 식품소재를 사용함으로써 독성 및 부작용이 없으며, 저렴한 생산비용과 사용의 편이성을 제공할 수 있다. 또한, 본 발명의 면역보강제는 면역원과 경구투여 시 경구감염성 병원성 미생물은 물론 비경구감염성 병원성 미생물이나 바이러스, 암 항원, 일반 항원 등에 대하여도 Th1 및 Th2 반응을 유도하며 효과적인 특이항체 (혈중 IgG 및 소장 IgA)를 생산할 수 있다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)